Medication info
Adicab Tablet 30/2.5 mg

Adicab Tablet 30/2.5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›33.005mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
White round-edged square film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300083 · Approved 2023.01.06 · Insurance code 693202500

Summary

Main use
Treatment of essential hypertension not adequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is required for older adults aged 70 years or younger. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in children and adolescents aged 18 years or younger.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Pimasartan potassium is a medication used when blood pressure control is difficult with monotherapy in patients with essential hypertension. This medication effectively lowers blood pressure and helps reduce the risk of cardiovascular disease. Therefore, it is suitable for individuals struggling with blood pressure management and is used to improve blood pressure control in essential hypertension.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, switching directly to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. No initial dose adjustment is required for older adults aged 70 years or younger. No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with fimasartan 30 mg in this medicine. No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in children and adolescents aged 18 years or younger.

Precautions

This medication can cause serious harm or risk of death to the fetus and newborn when taken during pregnancy, especially in the second and third trimesters; therefore, it should be discontinued immediately upon confirmation of pregnancy. Patients with allergies to the active ingredients or related components, those who are pregnant or breastfeeding, patients undergoing renal dialysis, those with severely impaired liver function, patients with biliary obstruction, and certain diabetic patients should not take this medication. Patients with reduced blood volume or impaired kidney function, patients with renovascular hypertension, aortic stenosis, severe hypotension, the elderly, and patients with allergies to certain pigment components should be particularly cautious when administering this medication. This medication may cause side effects such as dizziness, headache, facial and peripheral edema, urinary disorders, insomnia, and flushing, and in rare cases, serious neurological, gastrointestinal, or cardiovascular adverse reactions have been reported. Hypotension, electrolyte imbalance, especially elevated potassium levels, may occur during treatment, so the patient's condition should be regularly monitored and tested before and during treatment. Interactions may occur when combined with other antihypertensive agents, diuretics, potassium-sparing diuretics, and non-steroidal anti-inflammatory drugs, so consultation with a physician or pharmacist is necessary. Pregnant or nursing women are advised not to take this medication, and if necessary, should discuss thoroughly with a physician. The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established, so its use should be avoided. In the case of overdose, severe hypotension, cardiac arrhythmias, shock, etc., may occur, and immediate medical attention should be sought for appropriate treatment. This medication should be kept out of the reach of children, and it is advisable not to transfer it to other containers. Drowsiness or dizziness may occur during treatment, so caution is advised when driving or operating dangerous machinery.

Side effects

Dizziness, orthostatic dizziness, headache, facial swelling, peripheral edema, urination disorders, insomnia, flushing, syncope, sedation, migraine, dyspepsia, vomiting, nausea, upper abdominal pain, weakness, foreign body sensation, elevated liver enzyme levels, decreased platelet count, increased serum creatine phosphokinase, cough, muscle contraction, musculoskeletal stiffness, itching, localized urticaria, facial flushing, erectile dysfunction, epilepsy, amyotrophic lateral sclerosis, neuropathy, neuronitis, facial paralysis, normal pressure hydrocephalus, spinal stenosis, acute pancreatitis, intestinal obstruction, hemorrhagic duodenal ulcer, appendicitis, hemorrhoids, abdominal pain, intracranial hemorrhage, transient ischemic attack, atherosclerosis, worsening cerebral infarction, cerebral hemorrhage, liver cancer, colorectal carcinoma, neoplasm of unknown origin, cervical cancer, prostate cancer, acute kidney failure, chronic kidney failure, kidney stones, pyelonephritis, urinary incontinence, rhinitis, pneumonitis, pharyngitis, pneumonia, pulmonary disease, death, worsening low back pain, osteoarthritis, arthrosis, hypoglycemia, hyperkalemia, pulmonary embolism, purpura, bradycardia, atrial fibrillation, coronary artery disease, aortic stenosis, heart failure, increased blood pressure, acute hepatitis, benign pituitary neoplasm, otitis media, uterine prolapse, recurrent cancer, chest pain, weakness, fatigue, pain, weight gain, weight loss, hypotension, vasculitis, tension exacerbation, sensory impairment, sensory abnormalities, peripheral neuropathy, taste disturbances, tremors, extrapyramidal disorder, gynecomastia, changes in bowel habits, dry mouth, gastritis, gingival hypertrophy, pancreatitis, hyperglycemia, arthralgia, low back pain, muscle cramps, myalgia, leukopenia, thrombocytopenia, mood changes, dyspnea, hair loss, hyperhidrosis, purpura, skin discoloration, urticaria, toxic epidermal necrolysis, tinnitus, visual disturbances, increased urination frequency, nocturia, hepatitis, jaundice, pruritus, vascular edema, erythema multiforme, myocardial infarction, arrhythmia, chest pain, blood pressure reduction, sinoatrial block, atrioventricular block, abdominal discomfort, precordial pain, diarrhea, loose stools, constipation, skin hyperemia, maculopapular rash, heaviness, heat sensation, impaired glucose tolerance, weakness, reversible increase in serum lithium and toxicity, blood pressure reduction, syncope, hyperkalemia, decreased renal function, acute renal failure, increased blood pressure, blood pressure reduction, blood pressure variability, increased blood pressure, purpura, fatty liver, tinnitus, hearing impairment, hearing loss, pelvic inflammatory disease, vaginitis, prostate enlargement, scrotal pain, blood pressure variability

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a special container that keeps light and air out, and the storage temperature should be maintained between 1 to 30 degrees Celsius room temperature. Storing it this way will help maintain its effectiveness and safety.

Appearance and packaging

Appearance

White round-edged square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.